160 related articles for article (PubMed ID: 8624858)
1. An animal model of bullous pemphigoid: what can it teach us?
Giudice GJ; Liu Z; Diaz LA
Proc Assoc Am Physicians; 1995 Jul; 107(2):237-41. PubMed ID: 8624858
[TBL] [Abstract][Full Text] [Related]
2. The desmosome and hemidesmosome in cutaneous autoimmunity.
Lin MS; Mascaró JM; Liu Z; España A; Diaz LA
Clin Exp Immunol; 1997 Jan; 107 Suppl 1():9-15. PubMed ID: 9020929
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune response against the bullous pemphigoid 180 autoantigen.
Liu Z; Diaz LA; Giudice GJ
Dermatology; 1994; 189 Suppl 1():34-7. PubMed ID: 7519485
[TBL] [Abstract][Full Text] [Related]
4. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain.
Giudice GJ; Emery DJ; Zelickson BD; Anhalt GJ; Liu Z; Diaz LA
J Immunol; 1993 Nov; 151(10):5742-50. PubMed ID: 8228259
[TBL] [Abstract][Full Text] [Related]
5. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
[TBL] [Abstract][Full Text] [Related]
6. Molecular mapping of a pathogenically relevant BP180 epitope associated with experimentally induced murine bullous pemphigoid.
Liu Z; Diaz LA; Swartz SJ; Troy JL; Fairley JA; Giudice GJ
J Immunol; 1995 Dec; 155(11):5449-54. PubMed ID: 7594563
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
[TBL] [Abstract][Full Text] [Related]
8. Experimental animal models of bullous pemphigoid.
Heimbach L; Li N; Diaz A; Liu Z
G Ital Dermatol Venereol; 2009 Aug; 144(4):423-31. PubMed ID: 19755945
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to desmogleins 1 and 3, but not to BP180, induce blisters in human skin grafted onto SCID mice.
Zillikens D; Schmidt E; Reimer S; Chimanovitch I; Hardt-Weinelt K; Rose C; Bröcker EB; Kock M; Boehncke WH
J Pathol; 2001 Jan; 193(1):117-24. PubMed ID: 11169524
[TBL] [Abstract][Full Text] [Related]
10. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning of a cDNA encoding the porcine type XVII collagen noncollagenous 16 A domain and localization of the domain to the upper part of porcine skin basement membrane zone.
Xu L; Olivry T; Chan LS
Vet Dermatol; 2004 Jun; 15(3):146-51. PubMed ID: 15214950
[TBL] [Abstract][Full Text] [Related]
12. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180.
Liu Z; Diaz LA; Troy JL; Taylor AF; Emery DJ; Fairley JA; Giudice GJ
J Clin Invest; 1993 Nov; 92(5):2480-8. PubMed ID: 7693763
[TBL] [Abstract][Full Text] [Related]
13. Repetitive immunization breaks tolerance to type XVII collagen and leads to bullous pemphigoid in mice.
Hirose M; Recke A; Beckmann T; Shimizu A; Ishiko A; Bieber K; Westermann J; Zillikens D; Schmidt E; Ludwig RJ
J Immunol; 2011 Aug; 187(3):1176-83. PubMed ID: 21705619
[TBL] [Abstract][Full Text] [Related]
14. IgE autoantibodies against the intracellular domain of BP180.
Dresow SK; Sitaru C; Recke A; Oostingh GJ; Zillikens D; Gibbs BF
Br J Dermatol; 2009 Feb; 160(2):429-32. PubMed ID: 18808416
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180.
Zillikens D; Caux F; Mascaro JM; Wesselmann U; Schmidt E; Prost C; Callen JP; Bröcker EB; Diaz LA; Giudice GJ
J Invest Dermatol; 1999 Jul; 113(1):117-21. PubMed ID: 10417629
[TBL] [Abstract][Full Text] [Related]
16. What's new in bullous pemphigoid.
Ujiie H; Shibaki A; Nishie W; Shimizu H
J Dermatol; 2010 Mar; 37(3):194-204. PubMed ID: 20507382
[TBL] [Abstract][Full Text] [Related]
17. IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180.
Perriard J; Jaunin F; Favre B; Büdinger L; Hertl M; Saurat JH; Borradori L
J Invest Dermatol; 1999 Feb; 112(2):141-7. PubMed ID: 9989787
[TBL] [Abstract][Full Text] [Related]
18. Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid.
Leighty L; Li N; Diaz LA; Liu Z
Arch Dermatol Res; 2007 Nov; 299(9):417-22. PubMed ID: 17879094
[TBL] [Abstract][Full Text] [Related]
19. Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida.
Bédane C; McMillan JR; Balding SD; Bernard P; Prost C; Bonnetblanc JM; Diaz LA; Eady RA; Giudice GJ
J Invest Dermatol; 1997 Jun; 108(6):901-7. PubMed ID: 9182819
[TBL] [Abstract][Full Text] [Related]
20. Antiplectin autoantibodies in subepidermal blistering diseases.
Buijsrogge JJ; de Jong MC; Kloosterhuis GJ; Vermeer MH; Koster J; Sonnenberg A; Jonkman MF; Pas HH
Br J Dermatol; 2009 Oct; 161(4):762-71. PubMed ID: 19566666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
